Inselspital University Hospital Bern
Inselspital University Hospital Bern is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A Randomized, Double-Masked, Placebo-Controlled Study Assessing the Efficacy and Safety Of Privosegtor (OCS-05) as add-on to IV Methylprednisolone in Participants with Optic Neuritis (PIONEER 1)
Sponsor Oculis Operations SARL
- Start (EU)
- Not reported
- Latest update
- Estimated end
A prospective, randomised, Controlled, Open-label, Multicentre phase III study to evaluate efficacy and safety of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-Edotreotide compared to targeted molecular therapy with Everolimus in patients with inoperable, progressive, somatostatin receptor-positive (SSTR+), neuroendocrine tumours of gastroenteric or pancreatic origin (GEP-NET).
Sponsor ITM Solucin GmbH
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Inselspital University Hospital Bern?
The 2026-10-09 snapshot links Inselspital University Hospital Bern to 2 distinct CTIS trials. Recorded services include Central reading center activities., Histopathology. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Inselspital University Hospital Bern?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Inselspital University Hospital Bern conducted?
The linked trials record locations in 9 countries, including Germany, Spain, France, Italy, Poland. These are trial locations, not confirmed office locations or countries where Inselspital University Hospital Bern delivered services.
What can this page tell me about Inselspital University Hospital Bern's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Inselspital University Hospital Bern. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Inselspital University Hospital Bern